Dolutegravir for treatment of HIV: SPRING forwards?
- PMID: 23306001
- DOI: 10.1016/S0140-6736(12)62004-2
Dolutegravir for treatment of HIV: SPRING forwards?
Comment on
-
Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study.Lancet. 2013 Mar 2;381(9868):735-43. doi: 10.1016/S0140-6736(12)61853-4. Epub 2013 Jan 8. Lancet. 2013. PMID: 23306000 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
